テック

NECと中外製薬、AIでがん治療薬の予測をスピードアップ

NEC Corporation and Chugai Pharmaceutical Co., Ltd. worked together on an AI experiment. Their goal was to enhance cancer treatment by predicting better drug combinations more efficiently. The initiative showed that AI might cut the time to create drug combination predictions by half. This is a big improvement over Chugai’s old research methods. Combination therapies use multiple drugs to provide better benefits than single-agent treatments. Finding good drug pairings often needs a lot of manual work. This includes studying disease mechanisms, drug actions, and clinical uses. It also involves sifting through large databases of research papers and clinical trials. NEC created an AI system using proprietary graph-based algorithms. This system analyzes large biochemical datasets, focusing on the AACT and ChEMBL databases. Inputting a specific cancer treatment drug lets the system…